Biotech Values

[goldenbearking]

A doc who attended TRCA's study meeting in New Orleans stated that a TRCA executive told him they had approximately 150 paying patients. So basically, TRCA 150 for a full year, INSM 130 for 6 months. I think we can conclude who was the dominate force in the marketplace.